Inventor
MI CHEN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
C07CAcyclic or carbocyclic compounds6%
C07HSugars6%
C07KPeptides6%
PatentTitleYear
12,319,702Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors202512,134,610Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof202411,713,324Gonadotropin-releasing hormone receptor antagonists and methods relating thereto202311,685,745Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors202311,479,540Nonpeptide somatostatin type 5 receptor agonists and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to CRINETICS PHARMACEUTICALS INC (2)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to DART NEUROSCIENCE LLC (2)· patent assignee history
2023Patents assigned to NEUROCRINE BIOSCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CRINETICS PHARMACEUTICALS INC | 2 | 2022–2024 |
| DART NEUROSCIENCE LLC | 2 | 2023–2025 |
| NEUROCRINE BIOSCIENCES INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |